NPX-101 is a portable home device for the treatment of moderate to severe depression, boasting more effective and safer outcomes, based on information deposited and received from the Cloud.

Project Information

NPX-101

Grant agreement ID: 728611

DOI 10.3030/728611

Project closed

EC signature date 26 July 2016

Start date 1 June 2016

End date 30 September 2016

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

NEUROPREX EUROPE INC LTD
United Kingdom